Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-11-26

Clinical Trial Update: Determine Effects of Adjunctive Levetiracetam on Sleep Architecture in Adults With Partial Onset Epilepsy. [Phase 4]

View source ↗

Summary

A Phase 4 trial assessed whether adjunctive levetiracetam affects sleep architecture in adults with partial-onset epilepsy; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LEVETIRACETAM (levetiracetam)

Snippet

Sponsor: UCB Pharma | Conditions: Epilepsy, Partial | Phase 4 | Status: COMPLETED